<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02411461</url>
  </required_header>
  <id_info>
    <org_study_id>VR7195</org_study_id>
    <secondary_id>1K23DK101689-01A1</secondary_id>
    <nct_id>NCT02411461</nct_id>
  </id_info>
  <brief_title>Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism</brief_title>
  <official_title>Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and
      learning difficulties. This study will investigate eating behaviors and perform cognitive
      testing on children with PHP1a. The investigators will compare their results to those of
      healthy siblings and other obese children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pseudohypoparathyroidism type 1a (PHP1a) is a genetic disorder that causes early-onset,
      syndromic obesity and cognitive impairment. This study aims to evaluate eating behaviors,
      cognition and executive function in children with PHP1a, compared with healthy siblings and
      matched obese controls.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Kcals consumed during an ad lib meal</measure>
    <time_frame>one day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intelligence quotient</measure>
    <time_frame>one day</time_frame>
    <description>IQ measured by KBIT</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">42</enrollment>
  <condition>Pseudohypoparathyroidism</condition>
  <condition>Albright Hereditary Osteodystrophy</condition>
  <arm_group>
    <arm_group_label>Pseudohypoparathyroidism type 1a</arm_group_label>
    <description>Study group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy siblings</arm_group_label>
    <description>Control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese patients</arm_group_label>
    <description>Control group</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Children with pseudohypoparathyroidism type 1a (PHP1a), their healthy siblings and matched
        obese controls
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of PHP1a, sibling of a patient with PHP1a or matched obese control

        Exclusion Criteria (PHP1a):

          -  Treatment with appetite-altering drug or initiation of a new weight loss program in
             the past 3 months

          -  Type 2 diabetes

        Exclusion Criteria (Controls):

          -  Obesity due to a genetic syndrome, growth hormone deficiency, untreated
             hypothyroidism, Cushing syndrome or exogenous glucocorticoid administration

          -  Weight loss greater than 10% over the previous 6 months

          -  Autism or other significant learning disorder

          -  Type 2 diabetes

          -  Other significant medical condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashley Shoemaker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.facebook.com/pseudohypoparathyroidism</url>
    <description>Vanderbilt PHP Research Group Website</description>
  </link>
  <reference>
    <citation>Shoemaker AH, Lomenick JP, Saville BR, Wang W, Buchowski MS, Cone RD. Energy expenditure in obese children with pseudohypoparathyroidism type 1a. Int J Obes (Lond). 2013 Aug;37(8):1147-53. doi: 10.1038/ijo.2012.200. Epub 2012 Dec 11.</citation>
    <PMID>23229731</PMID>
  </reference>
  <reference>
    <citation>Wang L, Shoemaker AH. Eating behaviors in obese children with pseudohypoparathyroidism type 1a: a cross-sectional study. Int J Pediatr Endocrinol. 2014;2014(1):21. doi: 10.1186/1687-9856-2014-21. Epub 2014 Oct 15.</citation>
    <PMID>25337124</PMID>
  </reference>
  <reference>
    <citation>Landreth H, Malow BA, Shoemaker AH. Increased Prevalence of Sleep Apnea in Children with Pseudohypoparathyroidism Type 1a. Horm Res Paediatr. 2015;84(1):1-5. doi: 10.1159/000381452. Epub 2015 Apr 23.</citation>
    <PMID>25925491</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2015</study_first_submitted>
  <study_first_submitted_qc>April 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2015</study_first_posted>
  <last_update_submitted>January 17, 2017</last_update_submitted>
  <last_update_submitted_qc>January 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Ashley Shoemaker</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatrics, Pediatric Endocrinology and Diabetes</investigator_title>
  </responsible_party>
  <keyword>Pediatric obesity</keyword>
  <keyword>pseudohypoparathyroidism</keyword>
  <keyword>Albright Hereditary Osteodystrophy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Pseudohypoparathyroidism</mesh_term>
    <mesh_term>Pseudopseudohypoparathyroidism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>February 28, 2018</submitted>
    <returned>March 27, 2018</returned>
    <submitted>April 2, 2018</submitted>
    <returned>May 3, 2018</returned>
    <submitted>May 8, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

